
Ocular Therapeutix Inc (OCUL)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -48.264 | -97.24 | -93.37 | -113.81 | -91.389 | -2.808 | -40.115 | -40.232 |
Return on Equity (%) | -63.142 | -162.206 | -193.409 | -535.723 | -429.548 | -7.987 | -115.155 | -127.636 |
Return on Invested Capital (%) | -51.272 | -122.163 | -129.854 | -175.165 | -78.809 | -61.63 | -69.824 | -65.366 |
Operating Margin (%) | -2279.968 | -3197.816 | -2926.583 | -1899.006 | -855.416 | 0.271 | -124.317 | -118.745 |
Net Profit Margin (%) | -2368.998 | -3296.204 | -3013.97 | -2043.34 | -894.306 | -15.057 | -137.954 | -138.145 |
Book Value Per Share | 2.078 | 1.045 | 0.864 | -0.072 | 1.001 | 1.147 | 0.458 | 1.147 |
Earnings Per Share | -1.786 | -2.533 | -1.445 | -1.716 | -2.048 | -0.085 | -0.92 | -1.017 |
Cash Per Share | 1.316 | 1.66 | 1.302 | 1.082 | 3.001 | 2.139 | 1.325 | 2.465 |
Working Capital Per Share | 2.462 | 1.195 | 1.133 | 0.956 | 2.888 | 2.15 | 1.272 | 2.485 |
Operating Profit Per Share | 0.058 | 0.059 | 0.037 | 0.038 | 0.202 | 0.51 | 0.636 | 0.707 |
EBIT Per Share | -1.786 | -2.533 | -1.445 | -1.716 | -2.048 | -0.085 | -0.92 | -1.017 |
EBITDA Per Share | -1.786 | -2.533 | -1.445 | -1.716 | -2.048 | -0.085 | -0.92 | -1.017 |
Free Cash Flow Per Share | -1.745 | -2.268 | -1.454 | -1.722 | -2.073 | -0.101 | -0.899 | -0.977 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 25,02M | 25,02M | 41,52M | 50,33M | 76M | 76,73M | 77,2M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 77,2M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -213.474 | N/A | N/A | N/A | -411.513 | N/A | N/A |
Net Profit Margin (%) | N/A | -226.694 | N/A | N/A | N/A | -438.933 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,02B |
Ratio cours/bénéfice | -13,83 |
Ratio prix/ventes | 19,1 |
Ratio prix/liquidités | 5,7 |
Ratio prix/valeur comptable | 12,25 |
Rendement de dividende | - |
Actions en circulation | 157,22M |
Volume moyen (1 semaine) | 1,76M |
Volume moyen (1 mois) | 1,17M |
Variation sur 52 semaines | -34,27% |
Plus haut sur 52 semaines | 11,775 |
Plus bas sur 52 semaines | 4,06 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales